Dimensional Fund Advisors LP Iovance Biotherapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,822,758 shares of IOVA stock, worth $6.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,822,758

Previous 2,928,736 3.62%

Holding current value

$6.97 Million

Previous $5.04 Million 21.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$1.7 - $3.97 $180,162 - $420,732	-105,978 Reduced 3.62%	2,822,758 $6.13 Million
Q2 2025 Aug 12, 2025	SELL	$1.66 - $3.61 $958,437 - $2.08 Million	-577,372 Reduced 16.47%	2,928,736 $5.04 Million
Q1 2025 May 13, 2025	BUY	$3.33 - $7.79 $3.58 Million - $8.38 Million	1,075,887 Added 44.27%	3,506,108 $11.7 Million
Q4 2024 Feb 13, 2025	BUY	$7.17 - $12.28 $2.59 Million - $4.43 Million	360,629 Added 17.43%	2,430,221 $18 Million
Q3 2024 Nov 07, 2024	SELL	$7.28 - $11.9 $1.43 Million - $2.33 Million	-195,963 Reduced 8.65%	2,069,592 $19.4 Million

Q2 2024 Aug 09, 2024	SELL	$7.78 - $14.19 $4.71 Million - $8.6 Million	-605,943 Reduced 21.1%	2,265,555 $18.2 Million
Q1 2024 May 10, 2024	SELL	$7.59 - $17.47 $4.9 Million - $11.3 Million	-645,489 Reduced 18.35%	2,871,498 $42.6 Million
Q4 2023 Feb 07, 2024	SELL	$3.3 - $8.89 $1.52 Million - $4.1 Million	-461,398 Reduced 11.6%	3,516,987 $28.6 Million
Q3 2023 Nov 09, 2023	BUY	$4.44 - $8.79 $8.35 Million - $16.5 Million	1,881,382 Added 89.72%	3,978,385 $18.1 Million
Q2 2023 Aug 09, 2023	BUY	$5.36 - $9.06 $3.15 Million - $5.33 Million	587,770 Added 38.94%	2,097,003 $14.8 Million
Q1 2023 May 12, 2023	SELL	$5.53 - $8.22 $791,497 - $1.18 Million	-143,128 Reduced 8.66%	1,509,233 $9.22 Million
Q4 2022 Feb 09, 2023	SELL	$5.62 - $10.0 $57,054 - $101,520	-10,152 Reduced 0.61%	1,652,361 $10.6 Million
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $3.96 Million - $5.44 Million	415,153 Added 33.28%	1,662,513 $15.9 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $465,076 - $1.34 Million	72,896 Added 6.21%	1,247,360 $13.8 Million
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $3.59 Million - $5.54 Million	289,983 Added 32.79%	1,174,464 $19.6 Million
Q4 2021 Feb 09, 2022	BUY	$16.55 - $27.63 $9.16 Million - $15.3 Million	553,559 Added 167.28%	884,481 $16.9 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $3.19 Million - $4.17 Million	156,628 Added 89.86%	330,922 $8.16 Million
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $275,258 - $557,427	-16,856 Reduced 8.82%	174,294 $4.54 Million
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $1.5 Million - $2.76 Million	52,425 Added 37.79%	191,150 $6.04 Million
Q4 2020 Feb 25, 2021	BUY	$28.04 - $50.26 $3.89 Million - $6.97 Million	138,725 New	138,725 $6.44 Million

Others Institutions Holding IOVA

# of Institutions

292

Shares Held

219M

Call Options Held

2.41M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $390M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Iovance Biotherapeutics, Inc. Transaction History